R
Richard B. Kim
Researcher at University of Western Ontario
Publications - 380
Citations - 33088
Richard B. Kim is an academic researcher from University of Western Ontario. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 89, co-authored 328 publications receiving 30436 citations. Previous affiliations of Richard B. Kim include London Health Sciences Centre & St. Jude Children's Research Hospital.
Papers
More filters
Book ChapterDOI
Nuclear Receptors and Drug–Drug Interactions with Prescription and Herbal Medicines
Rommel G. Tirona,Richard B. Kim +1 more
Journal ArticleDOI
Association of Baclofen With Falls and Fractures in Patients With CKD.
Flory T. Muanda,Peter G. Blake,Matthew A. Weir,Lavanya Bathini,Kianna Chauvin,Stephanie N. Dixon,Eric McArthur,Jessica M. Sontrop,Louise Moist,Richard B. Kim,Amit X. Garg +10 more
Journal Article
Lacosamide for epilepsy
Mark Abramowicz,Gianna Zuccotti,Jean Marie Pflomm,Susan M. Daron,Blaine M. Houst,Corinne E. Zanone,Jules Hirsch,Gerald L. Mandell,Dan M. Roden,Carl W. Bazil,Vanessa K. Dalton,Eric J. Epstein,David N. Juurlink,Richard B. Kim,Hans Meinertz,Sandip K. Mukherjee,F. Estelle R. Simons,Jordan W. Smoller,Neal H. Steigbigel,Lauren K. Schwartz,Manouchkathe Cassagnol,Donna Goodstein,Amy Faucard,Cynthia Macapagal Covey,Susie Wong,Liz Donohue,Cheryl Brown,Gene Carbona,Cristine Romatowski,Joanne F. Valentino,Yosef Wissner-Levy +30 more
Journal ArticleDOI
Targeting the IκB Kinase Enhancer and Its Feedback Circuit in Pancreatic Cancer.
Sridevi Challa,Kazim Husain,Richard B. Kim,Domenico Coppola,Surinder K. Batra,Jin Q. Cheng,Mokenge P. Malafa +6 more
TL;DR: Depletion of IKBKE was found to significantly reduce PDAC cell survival, growth, cancer stem cell renewal, and cell migration and invasion, and it was demonstrated that the I KBKE inhibitors synergize with the MEK inhibitor trametinib to significantly induce cell death and inhibit tumor growth and liver metastasis in an orthotopic PDAC mouse model.
Journal ArticleDOI
Genome-Wide De Novo Variants in Congenital Heart Disease Are Not Associated With Maternal Diabetes or Obesity
Sarah U. Morton,Alexandre C. Pereira,Daniel Quiat,Felix Richter,A.I. Kitaygorodsky,Jacob Hagen,Daniel Bernstein,Martina Brueckner,Elizabeth Goldmuntz,Richard B. Kim,Richard P. Lifton,George A. Porter,Martin Tristani-Firouzi,Wendy K. Chung,Amy E. Roberts,Bruce D. Gelb,Yufeng Shen,Jane W. Newburger,Jonathan G. Seidman,Christine E. Seidman +19 more
TL;DR: The offspring of diabetic or obese mothers have no increase in DNVs compared with other children with CHD, emphasizing the role for other mechanisms in the cause of CHD associated with these prenatal exposures.